Abstract
This chapter presents the long-term results of stem cell therapy and core decompression in a patient with bilateral osteonecrosis of the femoral head. This case demonstrates that persistent hip pain, especially with joint movement, tenderness, or reduced range of motion, warrants magnetic resonance imaging because of the association of glucocorticoid therapy with osteonecrosis. The pathognomonic, subchondral crescent sign seen on radiographic examination may not be present in the early stages of osteonecrosis, and MRI can reveal extensive osteonecrosis before any change in the shape of the femoral head or appearance of a fracture crescent on X-rays.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp. 1932;50:137–95.
Boland EW, Headley NE. Management of rheumatoid arthritis with smaller (maintenance) doses of cortisone acetate. JAMA. 1950;144:365–72.
Bollet AJ, Black R, Bumin JJ. Major undesirable side-effects resulting from prednisolone and prednisone. JAMA. 1955;157:459–63.
Freyberg RH, Traeger CH, Patterson M, et al. Problems of prolonged cortisone treatment for rheumatoid arthritis. JAMA. 1951;147:1538–43.
Heiman WG, Freiberger RH. Avascular necrosis of the femoral and humeral heads after high-dosage corticosteroid therapy. N Engl J Med. 1960;263:672–5.
Hernigou P, Beaujean F, Lambotte JC. Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg Br. 1999;81(2):349.
Hernigou P, Poignard A, Manicom O, et al. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br. 2005;87(7):896.
Houdek MT, Wyles CC, Packard BD, Terzic A, Behfar A, Sierra RJ. Decreased osteogenic activity of mesenchymal stem cells in patients with corticosteroid-induced osteonecrosis of the femoral head. J Arthroplasty. 2016;31(4):893–8.
Lee HS, Huang GT, Chiang H, et al. Multipotent mesenchymal stem cells from femoral bone marrow near the site of osteonecrosis. Stem Cells. 2003;21:190.
Liberman JR. Core decompression for osteonecrosis of hip. Clin Orthop. 2004;418:29.
LoCascio V, Bonucci E, Imbimbo B, et al. Bone loss in response to long-term glucocorticoid therapy. Bone Miner. 1990;8:39–51.
Lorio R, Healy WL, Abramowitz AJ, et al. Clinical outcome and survivorship analysis of core decompression for early osteonecrosis of the femoral head. J Arthroplasty. 1998;13(1):34.
Mont MA, Cherian JJ, Sierra RJ, Jones LC, Lieberman JR. Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update. J Bone Joint Surg Am. 2015;97(19):1604–27.
Nash JJ, Nash AG, Leach ME, et al. Medical malpractice and corticosteroid use. Otolaryngol Head Neck Surg. 2011;144:10–5.
Pietrogrande V, Mastromarino R. Osteopathia da prolungato trattmento cortisonico. Ortop Tramat. 1957;25:791–810.
Weinstein RS. Clinical practice: glucocorticoid-induced bone disease. N Engl J Med. 2011;365:62–70.
Wyles CC, Houdek MT, Behfar A, Sierra RJ. Mesenchymal stem cell therapy for osteoarthritis: current perspectives. Stem Cells Cloning. 2015;8:117–24.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Mayo Foundation for Medical Education and Research
About this chapter
Cite this chapter
Hernigou, P., Dubory, A., Potage, D., Lachaniette, C.H.F. (2017). Bilateral Osteonecrosis Associated with Corticosteroid Treatment: Stem Cell Therapy Versus Core Decompression in the Same Patient. In: Sierra, R. (eds) Osteonecrosis of the Femoral Head. Springer, Cham. https://doi.org/10.1007/978-3-319-50664-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-50664-7_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50662-3
Online ISBN: 978-3-319-50664-7
eBook Packages: MedicineMedicine (R0)